Pfizer
Director, Value and Evidence, COVID Antivirals
Pfizer, San Francisco, California, United States, 94199
Company:
PfizerLocation:
San Francisco, CAEmployment Type:
Full TimeDate Posted:
11/08/2024Job Categories:
Biotechnology and Pharmaceutical, Finance/Economics, Government and Policy, Healthcare, Other, Healthcare, Practitioner and Technician, Legal, Manufacturing and Production, Franchising, Research & Development, MedicalJob DescriptionDirector, Value and Evidence, COVID AntiviralsROLE SUMMARYThe
Director, HTA, Value & Evidence (HV&E) - Antivirals
will support the strategic goals of the Primary Care Division by driving optimal patient access for Antiviral medicines. This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal patient access by demonstrating the value of our Antiviral medicines. The HV&E Director will be responsible for developing and executing against the global evidence generation strategy, including direct oversight of evidence generation activities and dissemination of technical deliverables.This position will be part of Pfizer's dynamic Global Access & Value (GAV) team and will have the important role of managing health economics and outcomes research (HEOR) to generate data to support patient access to Antiviral medicines, with a primary focus on pipeline Antiviral assets. Based on the needs of the antiviral franchise, this colleague is expected to work across different geographies as well as on launch or pipeline assets. Flexibility is expected seeing the evolving needs of the antiviral franchise. This position will be working closely with the Antiviral GAV, cross-functional and country teams to foster a culture that promotes innovation and thrives on doing better for Pfizer's patients and healthcare.ROLE RESPONSIBILITIESLead the development of the evidence generation strategy to support the value of Antiviral pipeline assets in the Primary Care Division in close partnership with the cross-functional matrix team.Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the evidence strategy to support global market access needs at launch and through lifecycle.Lead the design and execution of global HEOR studies (e.g., economic models, network meta-analyses, non-interventional studies) from concept through publication.Develop patient-reported outcomes strategy and incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements.Lead the timely development of launch deliverables including value & evidence strategy, global value dossiers/AMCP dossiers, systematic literature reviews, economic models, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries.Partner with internal stakeholders to ensure appropriate customer facing dissemination of HEOR materials per regulatory guidance and internal SOPs.Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community Antiviral settings to support asset strategies.BASIC QUALIFICATIONSGraduate degree minimum required (e.g. MSc, MPH, PhD)9+ years of experience required with MSc/MPH/MBA degree; 7+ years of experience required with PharmD/PhD in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)Demonstrated in depth understanding of fundamental health services research methods and tools, including health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies including technical and methodological aspects of registries and observational study design, implementation, analysis and interpretation.Knowledge and understanding of drug development processExcellent interpersonal skills required: ability to understand and respond to multiple internal and external customersExcellent oral and written English communication skillsDemonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordinglyAn "execution mindset" focused on getting things done quickly and simplyStrong project management abilities (contracting, budgeting, vendor management) essential.PREFERRED QUALIFICATIONSKnowledge and experience in the Infectious Disease therapeutic areaExperience with HTA organizations such as NICE, CADTH, PBAC, ICER and other HTA groupsOther Job Details:Last Date to Apply for Job: November 12th, 2024.Position is hybrid and will require to work from site 2 to 3 days per weekNOT Eligible for Relocation PackageAbility to travel domestically and international based on business needsThe annual base salary for this position ranges from $161,600.00 to $269,400.00.* In addition, this position is eligible for participation in Pfizer's Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life's moments.
#J-18808-Ljbffr
PfizerLocation:
San Francisco, CAEmployment Type:
Full TimeDate Posted:
11/08/2024Job Categories:
Biotechnology and Pharmaceutical, Finance/Economics, Government and Policy, Healthcare, Other, Healthcare, Practitioner and Technician, Legal, Manufacturing and Production, Franchising, Research & Development, MedicalJob DescriptionDirector, Value and Evidence, COVID AntiviralsROLE SUMMARYThe
Director, HTA, Value & Evidence (HV&E) - Antivirals
will support the strategic goals of the Primary Care Division by driving optimal patient access for Antiviral medicines. This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal patient access by demonstrating the value of our Antiviral medicines. The HV&E Director will be responsible for developing and executing against the global evidence generation strategy, including direct oversight of evidence generation activities and dissemination of technical deliverables.This position will be part of Pfizer's dynamic Global Access & Value (GAV) team and will have the important role of managing health economics and outcomes research (HEOR) to generate data to support patient access to Antiviral medicines, with a primary focus on pipeline Antiviral assets. Based on the needs of the antiviral franchise, this colleague is expected to work across different geographies as well as on launch or pipeline assets. Flexibility is expected seeing the evolving needs of the antiviral franchise. This position will be working closely with the Antiviral GAV, cross-functional and country teams to foster a culture that promotes innovation and thrives on doing better for Pfizer's patients and healthcare.ROLE RESPONSIBILITIESLead the development of the evidence generation strategy to support the value of Antiviral pipeline assets in the Primary Care Division in close partnership with the cross-functional matrix team.Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the evidence strategy to support global market access needs at launch and through lifecycle.Lead the design and execution of global HEOR studies (e.g., economic models, network meta-analyses, non-interventional studies) from concept through publication.Develop patient-reported outcomes strategy and incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements.Lead the timely development of launch deliverables including value & evidence strategy, global value dossiers/AMCP dossiers, systematic literature reviews, economic models, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries.Partner with internal stakeholders to ensure appropriate customer facing dissemination of HEOR materials per regulatory guidance and internal SOPs.Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community Antiviral settings to support asset strategies.BASIC QUALIFICATIONSGraduate degree minimum required (e.g. MSc, MPH, PhD)9+ years of experience required with MSc/MPH/MBA degree; 7+ years of experience required with PharmD/PhD in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)Demonstrated in depth understanding of fundamental health services research methods and tools, including health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies including technical and methodological aspects of registries and observational study design, implementation, analysis and interpretation.Knowledge and understanding of drug development processExcellent interpersonal skills required: ability to understand and respond to multiple internal and external customersExcellent oral and written English communication skillsDemonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordinglyAn "execution mindset" focused on getting things done quickly and simplyStrong project management abilities (contracting, budgeting, vendor management) essential.PREFERRED QUALIFICATIONSKnowledge and experience in the Infectious Disease therapeutic areaExperience with HTA organizations such as NICE, CADTH, PBAC, ICER and other HTA groupsOther Job Details:Last Date to Apply for Job: November 12th, 2024.Position is hybrid and will require to work from site 2 to 3 days per weekNOT Eligible for Relocation PackageAbility to travel domestically and international based on business needsThe annual base salary for this position ranges from $161,600.00 to $269,400.00.* In addition, this position is eligible for participation in Pfizer's Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life's moments.
#J-18808-Ljbffr